Experts discuss how endotyping and biomarkers can help to guide treatment selection in severe type 2 asthma - touchRESPIRATORY

touchPODCAST · Dec 3, 2021 · 40m

touchPANEL DISCUSSION for touchRESPIRATORY

Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma.

The experts

Dr Katharine Woessner, Scripps Clinic Medical Group, San Diego, CA, USA

Prof. Louis-Philippe Boulet, Laval University, Quebec City, Canada

Prof. Arnaud Bourdin, Arnaud de Villeneuve Hospital, Montpellier, France

This touchPODCAST is for HCPs only.

This…